{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:50:27Z","timestamp":1792450227154,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jaad.2017.08.058","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T09:43:24Z","timestamp":1515750204000},"page":"249-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"title":["Cutaneous squamous cell carcinoma"],"prefix":"10.1016","volume":"78","author":[{"given":"Syril Keena T.","family":"Que","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona O.","family":"Zwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysalyne D.","family":"Schmults","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.08.058_bib1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejrad.2007.02.037","article-title":"Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging","volume":"64","author":"de Bondt","year":"2007","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jaad.2017.08.058_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women\u2019s Hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cps.2009.08.001","article-title":"The role of lymphatic mapping and sentinel lymph node biopsy in the staging and treatment of melanoma","volume":"37","author":"Stadelmann","year":"2010","journal-title":"Clin Plast Surg"},{"key":"10.1016\/j.jaad.2017.08.058_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2016.08.051","article-title":"The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management","volume":"76","author":"Ruiz","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2015.10.010","article-title":"The role of imaging in the management of patients with nonmelanoma skin cancer: diagnostic modalities and applications","volume":"76","author":"MacFarlane","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.amjoto.2014.01.006","article-title":"Use of positron emission tomography scanning in metastatic head and neck cutaneous squamous cell cancer: does it add to patient management?","volume":"35","author":"Supriya","year":"2014","journal-title":"Am J Otolaryngol"},{"issue":"suppl 5","key":"10.1016\/j.jaad.2017.08.058_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04296.x","article-title":"French Dermatology Recommendations Association (aRED). Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions","volume":"25","author":"Bonerandi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2017.08.058_bib9","first-page":"S5","article-title":"Short German guidelines: squamous cell carcinoma","volume":"6","author":"Breuninger","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.08.058_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaad.2015.10.009","article-title":"The role of imaging in the management of patients with nonmelanoma skin cancer: when is imaging necessary?","volume":"76","author":"Humphreys","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejso.2014.10.055","article-title":"Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma","volume":"41","author":"Allen","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib12","first-page":"1309","article-title":"Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature","volume":"32","author":"Ross","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.08.058_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/1346-8138.12508","article-title":"Evaluation of sentinel node biopsy for cutaneous squamous cell carcinoma","volume":"41","author":"Fukushima","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaad.2015.03.039","article-title":"High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: a literature review","volume":"73","author":"Navarrete-Dechent","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib17","first-page":"135","article-title":"Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma","volume":"29","author":"Reschly","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.08.058_bib18","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/cncr.21898","article-title":"High-risk cutaneous squamous cell carcinoma of the head and neck","volume":"106","author":"Veness","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.08.058_bib19","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","volume":"51","author":"Stratigos","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2017.08.058_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.MLG.0000158349.64337.ED","article-title":"Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice","volume":"115","author":"Veness","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaad.2017.08.058_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hed.21743","article-title":"Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient","volume":"34","author":"Ebrahimi","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.jaad.2017.08.058_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/hed.2880130510","article-title":"Carcinoma of the skin metastatic to parotid area lymph nodes","volume":"13","author":"Taylor","year":"1994","journal-title":"Head Neck"},{"key":"10.1016\/j.jaad.2017.08.058_bib23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hed.23684","article-title":"Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck","volume":"37","author":"Tanvetyanon","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.jaad.2017.08.058_bib24","first-page":"679","article-title":"Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations","volume":"30","author":"Martinez","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.08.058_bib25","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/1097-0142(19901015)66:8<1692::AID-CNCR2820660807>3.0.CO;2-Y","article-title":"Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin","volume":"66","author":"Sadek","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.08.058_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00000421-200004000-00015","article-title":"Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged","volume":"23","author":"Cartei","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.1990.8.2.342","article-title":"Cisplatin based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy","volume":"8","author":"Guthrie","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib28","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/1097-0142(19910415)67:8<2030::AID-CNCR2820670803>3.0.CO;2-K","article-title":"Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin","volume":"67","author":"Khansur","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.08.058_bib29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/00000421-200112000-00019","article-title":"Gemcitabine, cisplatin and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study","volume":"24","author":"Benasso","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1610-0387.2008.06861.x","article-title":"Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma","volume":"6","author":"Jalili","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.08.058_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2013.05.011","article-title":"An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma","volume":"69","author":"O\u2019Bryan","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib32","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1200\/JCO.2010.34.1735","article-title":"Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin","volume":"29","author":"Maubec","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.oraloncology.2014.10.010","article-title":"Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer\u2014review of current data","volume":"51","author":"Swanson","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib34","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.08.058_bib35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.oraloncology.2011.08.007","article-title":"Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma","volume":"47","author":"Cho","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib36","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hed.23706","article-title":"Expression profile and in\u00a0vitro blockade of programmed death-1 in human papillomavirus-negative head and neck squamous cell carcinoma","volume":"37","author":"Malm","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.jaad.2017.08.058_bib37","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2017.08.058_bib38","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/bjd.14642","article-title":"Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases","volume":"175","author":"Borradori","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamadermatol.2016.3884","article-title":"Follow-up on programmed cell death 1 inhibitor for cutaneous squamous cell carcinoma","volume":"153","author":"Tran","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaad.2017.08.058_bib40","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1200\/JCO.2017.35.15_suppl.9503","article-title":"REGN2810: a fully human anti-PD-1 monoclonal antibody, for patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC)- initial safety and efficacy from expansion cohorts (ECs) of phase I study","volume":"35","author":"Papadopoulos","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib41","series-title":"ClinicalTrials.gov [Internet]","article-title":"Study of REGN2810 in patients with advanced cutaneous squamous cell carcinoma","year":"2000"},{"key":"10.1016\/j.jaad.2017.08.058_bib42","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/annonc\/mdw130","article-title":"Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma","volume":"27","author":"Spain","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib43","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/ajt.13711","article-title":"Checkpoint inhibitors in kidney transplant recipients and the potential risk of rejection","volume":"16","author":"Alhamad","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2017.08.058_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJMc1614298","article-title":"Preserved renal-allograft function and the PD-1 pathway inhibitor nivolumab","volume":"376","author":"Barnett","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.08.058_bib45","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/jamadermatol.2015.1702","article-title":"Outcomes of patients with multiple cutaneous squamous cell carcinomas: a 10-year single-institution cohort study","volume":"151","author":"Levine","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/DSS.0000000000001225","article-title":"Treatment patterns, outcomes and patient satisfaction of primary epidermally-limited non-melanoma skin cancer: non-surgical treatments perform comparably to Mohs surgery","author":"Drew","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.08.058_bib47","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0190-9622(91)70070-I","article-title":"Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study","volume":"24","author":"Misiewicz","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1067\/mjd.2003.451","article-title":"Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial","volume":"49","author":"Kang","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/09546634.2012.687088","article-title":"Non-ablative fractional resurfacing in combination with topical tretinoin cream as a field treatment modality for multiple actinic keratosis: a pilot study and a review of other field treatment modalities","volume":"24","author":"Prens","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.08.058_bib50","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Veterans Affairs Topical Tretinoin Chemoprevention Trial Group. Tretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): a Veterans Affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib51","doi-asserted-by":"crossref","first-page":"27402","DOI":"10.1038\/srep27402","article-title":"Photodynamic therapy inhibit fibroblast growth factor-10 induced keratinocyte differentiation and proliferation through ROS in fibroblast growth factor receptor-2b pathway","volume":"6","author":"Gozali","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaad.2017.08.058_bib52","first-page":"340","article-title":"Photodyamic therapy in dermatology","volume":"16","author":"Babilas","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib53","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-2133.2009.09119.x","article-title":"Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial","volume":"160","author":"Wiegell","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2133.2008.08450.x","article-title":"Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study","volume":"158","author":"Wiegell","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib55","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2011.10209.x","article-title":"A randomized, multicentre study of directed daylight exposure times of 1\u00bd vs 2\u00bd h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp","volume":"164","author":"Wiegell","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2133.2003.05033.x","article-title":"Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen\u2019s disease","volume":"148","author":"Salim","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pdpdt.2014.02.006","article-title":"Efficacy of topical ALA-PDT combined with excision in the treatment of skin malignant tumor","volume":"11","author":"Lu","year":"2014","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.jaad.2017.08.058_bib58","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1517\/14656566.9.8.1363","article-title":"Systemic retinoids in chemoprevention of non-melanoma skin cancer","volume":"9","author":"Lens","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaad.2017.08.058_bib59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.1988.tb03223.x","article-title":"The effect of oral retinoid therapy on the normal human immune system","volume":"119","author":"McKerrow","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib60","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM198806233182501","article-title":"Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin","volume":"318","author":"Kraemer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.08.058_bib61","first-page":"485","article-title":"Prevention of skin cancer in xeroderma pigmentosum with oral isotretinoin","volume":"43","author":"Moshell","year":"1989","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.08.058_bib62","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal recipients: a double blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib63","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1046\/j.1365-2133.1999.02765.x","article-title":"Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin","volume":"140","author":"McKenna","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib64","first-page":"562","article-title":"Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects","volume":"32","author":"Otley","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.08.058_bib65","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-0012.2005.00412.x","article-title":"Systemic strategies for chemoprevention of skin cancers in transplant recipients","volume":"19","author":"Kovach","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jaad.2017.08.058_bib66","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/carcin\/bgt017","article-title":"Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex\u00a0vivo skin","volume":"34","author":"Surjana","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2017.08.058_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/carcin\/bgn248","article-title":"Oral nicotinamide protects against ultraviolet radiation induced immunosuppression in humans","volume":"30","author":"Yiasemides","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2017.08.058_bib68","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer prevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.08.058_bib69","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.14662","article-title":"A phase II randomized\u00a0controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"175","author":"Chen","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib70","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s001250051536","article-title":"European Nicotinamide Diabetes Intervention Trial Group. Safety of high-dose nicotinamide: a review","volume":"43","author":"Knip","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaad.2017.08.058_bib71","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00432-004-0656-6","article-title":"Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin","volume":"131","author":"Wollina","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib72","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/dsu.12049","article-title":"Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients","volume":"39","author":"Endrizzi","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.08.058_bib73","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1399-0012.2010.01348.x","article-title":"Capecitabine for skin cancer prevention in solid organ transplant recipients","volume":"25","author":"Jirakulaporn","year":"2011","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jaad.2017.08.058_bib74","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/00007890-200205270-00008","article-title":"Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy","volume":"73","author":"Luan","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2017.08.058_bib75","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1399-0012.2004.00188.x","article-title":"Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies","volume":"18","author":"Mathew","year":"2004","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jaad.2017.08.058_bib76","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","article-title":"Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus","volume":"31","author":"Hoogendijk-van den Akker","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.08.058_bib77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"TUMORAPA Study Group. Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.08.058_bib78","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2015.5548","article-title":"Association of sirolimus use with risk for skin cancer in a mixed-organ cohort of solid-organ transplant recipients with a history of cancer","volume":"152","author":"Karia","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib79","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaad.2015.05.029","article-title":"Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)","volume":"73","author":"Asgari","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib80","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-4632.2009.04045.x","article-title":"Effectiveness of 5-fluorouracil treatment for actinic keratosis\u2014a systematic review of randomized controlled trials","volume":"48","author":"Askew","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib81","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2133.2003.05033.x","article-title":"Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen\u2019s disease","volume":"148","author":"Salim","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib82","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.jid.5700264","article-title":"Imiquimod for actinic keratosis: systematic review and meta-analysis","volume":"126","author":"Hadley","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib83","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaad.2006.01.055","article-title":"Imiquimod 5% cream\u00a0monotherapy for cutaneous squamous cell carcinoma in\u00a0situ (Bowen\u2019s disease): a randomized, double blind, placebo-controlled trial","volume":"54","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib84","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.08.058_bib85","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00403-005-0601-9","article-title":"Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies","volume":"297","author":"Pirard","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2017.08.058_bib86","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/jid.2014.531","article-title":"Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"135","author":"Muranushi","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.08.058_bib87","series-title":"American Joint Committee on Cancer Cancer Staging Manual","first-page":"171","article-title":"Cutaneous squamous cell carcinoma of the head and neck","year":"2017"},{"key":"10.1016\/j.jaad.2017.08.058_bib88","doi-asserted-by":"crossref","first-page":"836","DOI":"10.6004\/jnccn.2010.0062","article-title":"Basal cell and squamous cell skin cancers","volume":"8","author":"Miller","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"issue":"4 part 2","key":"10.1016\/j.jaad.2017.08.058_bib89","first-page":"642","article-title":"International Transplant-Skin Cancer Collaborative. European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients","volume":"30","author":"Stasko","year":"2004","journal-title":"Dermatol Surg"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217323241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217323241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:46:41Z","timestamp":1759272401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217323241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0190962217323241"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.08.058","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.08.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(17)32834-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}